Dishman Carbogen Amcis Stock Sees 7.6% Increase, Outperforms Sector and Sensex

Dishman Carbogen Amcis, a smallcap pharmaceutical company, saw a 7.6% increase in its stock price on November 18, 2024. This rise was in line with the overall performance of the sector, as the company outperformed the sector by 7.83%.

The stock has been on a consecutive gain for the past two days, with a total increase of 25.58% during this period. On November 18, the stock reached an intraday high of Rs 228.75, showing a strong performance for the day.

Dishman Carbogen Amcis is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.

In comparison to the Sensex, Dishman Carbogen Amcis has outperformed with a 1-day performance of 7.67% versus Sensex's -0.32%. Similarly, in the past month, the company has shown a 15.29% increase in its stock price, while the Sensex has declined by -4.79%.

Overall, Dishman Carbogen Amcis has shown a strong performance in the past few days, outperforming the sector and the Sensex. Investors may want to keep an eye on this smallcap pharmaceutical company as it continues to show positive growth.